Cervical Cancer Could Be Eliminated—But Millions Still Lack Vaccines and Care
November 17, 2026
Cervical cancer could become the first cancer eliminated as a public health problem through HPV vaccination, screening and timely treatment, yet it still causes more than 600,000 diagnoses and about 280,000 deaths each year.
Persistent infection with high-risk HPV causes almost all cervical cancer cases, making vaccination before sexual activity a key prevention measure; screening can catch precancerous changes before they become invasive cancer.
The WHO’s 2020 global strategy set “90-70-90” targets: vaccinate 90% of girls against HPV, screen 70% of women and treat 90% of those diagnosed with precancer or cancer.
HPV vaccination is now included in national immunization programmes in 166 countries, 96 countries use a simplified single-dose schedule, and India’s campaign has reached more than 11 million girls.
Even with that expansion, only 33% of eligible girls aged 9 to 14 are protected, and reaching girls outside routine or school-based programmes remains a challenge.
The disease burden falls disproportionately on poorer communities, with 19 of the 20 countries with the highest burden in the WHO African Region; stigma and limited access to care compound the harm.
Limited awareness, stigma around sexual and reproductive health, overstretched services and the cost of care remain major barriers.
Women living with HIV face a six-fold higher risk of cervical cancer, making sustained vaccination funding, expanded screening and access to treatment especially important for this group.
Elimination depends on making vaccines, diagnostic tests and treatment affordable and accessible, particularly in low- and middle-income countries, so women can benefit regardless of income or location.
HPV DNA testing and self-collected samples can make screening more effective, private and accessible, while portable treatment devices can help in areas with limited medical facilities.
AI tools that analyse cervical images and digitised Pap smear slides may help identify abnormalities where specialists are scarce, but Dr Jyoti Bajpai stresses that technology should complement—not replace—vaccination, screening and treatment.
Australia and Sweden are approaching elimination as a public health problem, while Rwanda is making progress, with several districts meeting key WHO targets.
Summary based on 4 sources
Get a daily email with more World News stories
Sources

The Telegraph • Nov 17, 2026
For the first time in public health history, the end of a cancer is in sight
Al Majalla • Nov 17, 2026
For the first time in history, the end of a cancer is in sight
Oncodaily - Oncology News, Insights, Stories • Nov 18, 2026
When a Woman is Saved, a Family is Saved and a Nation Rises – Pink Africa Foundation